2024-07-02 05:05:02 ET
Summary
- Cardlytics shares have declined significantly after Q1 earnings came in below management’s guidance.
- Key metrics show that the business is performing well.
- Recent steps taken by management have extended its debt until 2029, leaving the company in a more stable financial position.
- CDLX has multiple growth levers and significant risks that investors should consider.
Investment thesis
Read the full article on Seeking Alpha
For further details see:
Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain